Enrolled first three FTD-GRN patients in Cohort 3 of ongoing upliFT-D studyTreated first FTD-C9orf72 patient with Dose 2 PBFT02 in Cohort 4 of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results